Abstract
Background: hRad9 is a cell cycle checkpoint gene that is up-regulated in breast cancer. We have previously shown that the mRNA up-regulation correlated with tumor size and local recurrence. Immunohistochemical studies were made to better define the role of hRad9 in breast carcinogenesis. Methods: Localisation of hRad9 protein were performed on paired tumor and normal breast tissues. Immunoblotting with and without dephosphorylation was used to define the protein isolated from breast cancer cells. Results: Increased hRad9 protein was observed in breast cancer cells nucleus compared to non-tumor epithelium. This nuclear protein existed in hyperphosphorylated forms which may be those of the hRad9-hRad1-hHus1 complex. Conclusion: Finding of hyperphosphorylated forms of hRad9 in the nucleus of cancer cells is in keeping with its function in ameliorating DNA instability, whereby it inadvertently assists tumor growth. © 2008 Chan et al; licensee BioMed Central Ltd.
Cite
CITATION STYLE
Chan, V., Khoo, U. S., Wong, M. S., Lau, K., Suen, D., Li, G., … Chan, T. K. (2008). Localization of hRad9 in breast cancer. BMC Cancer, 8. https://doi.org/10.1186/1471-2407-8-196
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.